FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely chlorphenamine tannate 800 microgram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely beclometasone dipropionate 84 microgram/1 actuation conventional release nasal spray (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cefradine 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cefradine 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely thioridazine (as thioridazine hydrochloride) 100 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely thioridazine (as thioridazine hydrochloride) 100 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Ampicillin (as ampicillin sodium) 1 g powder for solution for injection vial Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Ampicillin (as ampicillin sodium) 1 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Ampicillin (as ampicillin sodium) 1 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Telbivudine 20 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Telbivudine 20 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Omeprazole (as omeprazole magnesium) 10 mg gastro-resistant oral capsule Count of base of active ingredient False un Inferred relationship Some
Omeprazole (as omeprazole magnesium) 10 mg gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Cocaine 100 mg/g nasal paste Count of base of active ingredient False un Inferred relationship Some
Cocaine 100 mg/g nasal paste Has concentration strength denominator value False un Inferred relationship Some 1
Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Ibuprofen 40 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
Ibuprofen 40 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet Has presentation strength denominator value False un Inferred relationship Some 2
Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely omeprazole 20 milligram/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely omeprazole 20 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Calcium electrolyte 1.25 g and cholecalciferol 10 microgram chewable tablet Has presentation strength denominator value False un Inferred relationship Some 1
Calcium electrolyte 1.25 g and cholecalciferol 10 microgram chewable tablet Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely baclofen 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely baclofen 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Estradiol 100 mg prolonged-release subcutaneous implant Has presentation strength denominator value False un Inferred relationship Some 1
Estradiol 100 mg prolonged-release subcutaneous implant Count of base of active ingredient False un Inferred relationship Some
Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value (attribute) False un Inferred relationship Some 1
Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Sevelamer carbonate 2.4 g powder for oral suspension sachet Has presentation strength denominator value False un Inferred relationship Some 1
Sevelamer carbonate 2.4 g powder for oral suspension sachet Count of base of active ingredient False un Inferred relationship Some
Product containing precisely plerixafor 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely plerixafor 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely acetazolamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely acetazolamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely macrogol 3350 17 gram/1 sachet powder for conventional release oral solution (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely macrogol 3350 17 gram/1 sachet powder for conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Nitroglycerin 600 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
Nitroglycerin 600 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
Diazepam 2 mg/mL rectal solution Count of base of active ingredient False un Inferred relationship Some
Diazepam 2 mg/mL rectal solution Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely diazepam 4 milligram/1 milliliter conventional release rectal solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely diazepam 4 milligram/1 milliliter conventional release rectal solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Risperidone 12.5 mg powder for suspension for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Risperidone 12.5 mg powder for suspension for injection vial Count of base of active ingredient False un Inferred relationship Some
Mesalamine 66.7 mg/mL rectal suspension Count of base of active ingredient False un Inferred relationship Some
Mesalamine 66.7 mg/mL rectal suspension Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely tenecteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely tenecteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely zoledronic acid 4 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely zoledronic acid 4 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Colesevelam hydrochloride 1.875 g powder for oral suspension sachet Count of base of active ingredient False un Inferred relationship Some
Colesevelam hydrochloride 1.875 g powder for oral suspension sachet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Risperidone 50 mg powder for suspension for injection vial Count of base of active ingredient False un Inferred relationship Some
Risperidone 50 mg powder for suspension for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Levonorgestrel 75 mg prolonged-release subcutaneous implant Count of base of active ingredient False un Inferred relationship Some
Levonorgestrel 75 mg prolonged-release subcutaneous implant Has presentation strength denominator value False un Inferred relationship Some 1
Fentanyl 12 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
Fentanyl 12 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
Product containing precisely colesevelam hydrochloride 3.75 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely colesevelam hydrochloride 3.75 gram/1 sachet powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 2
Sotalol hydrochloride 15 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Sotalol hydrochloride 15 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Ixabepilone 15 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Ixabepilone 15 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely pegloticase 8 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely pegloticase 8 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Sevelamer carbonate 800 mg powder for oral suspension sachet Has presentation strength denominator value False un Inferred relationship Some 1
Sevelamer carbonate 800 mg powder for oral suspension sachet Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ixabepilone 45 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ixabepilone 45 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely colestyramine 4 gram/1 sachet powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely colestyramine 4 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Cabazitaxel 40 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1

Start Previous Page 82 of 217 Next End


This concept is not in any reference sets

Back to Start